Security key
36315X101
Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") (LKFT)
CUSIP: 36315X101
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Ordinary shares, no nominal value per share (the "Ordinary Shares")
- Total 13F shares
- 12,830,797
- Total 13F value
- $795,810,983
- Share change
- +2,103,171
- Put/Call ratio
- 42%
- SEC-reported price per share
- $62.02
- Number of holders
- 86
- Value change
- +$134,250,057
- Number of buys
- 46
- Number of sells
- 43
- Shares outstanding
- 65,567,327
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
86
Top holders
10
LKFT full security history
Ownership snapshot
Full 13F holder table
Lakefront Biotherapeutics NV SEC filings
Lakefront Biotherapeutics NV company facts
Broader feeds
Ownership snapshot
Top reported holders of LKFT - Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EcoR1 Capital, LLC
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 3.4%
Showing 1-6 of 15 holder rows.
Quick read
EcoR1 Capital, LLC leads the comparable SEC ownership view at 3.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EcoR1 Capital, LLC's linked filing trail.
Comparable ownership
Top 5
EcoR1 Capital, LLC
3.4%
BVF INC/IL
1.8%
683 Capital Management, LLC
1.4%
Point72 Asset Management, L.P.
1.2%
ORBIMED ADVISORS LLC
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC |
13F
Company
|
3.4%
|
$122,631,000
2,224,403 shares
|
— | 31 Dec 2021 |
| BVF INC/IL |
13F
Company
|
1.8%
|
$63,752,000
1,156,393 shares
|
— | 31 Dec 2021 |
| 683 Capital Management, LLC |
13F
Company
|
1.4%
|
$49,900,000
905,121 shares
|
— | 31 Dec 2021 |
| Point72 Asset Management, L.P. |
13F
Company
|
1.2%
|
$42,114,000
763,900 shares
|
— | 31 Dec 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.1%
|
$39,542,000
717,257 shares
|
— | 31 Dec 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.79%
|
$28,678,000
520,188 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
86
Shares
12,830,797
Rows available
86
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q1 2022 Across Filers
Q1 2022 holders
86
Q1 2022 holders
86
Holder diff
0
| Investor | Q1 2022 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q1 2022 value | Value change | Value Chg % |
|---|